Novo Nordisk Inc Drug Patent Portfolio

Novo Nordisk Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Novo Nordisk Inc News

Novo Nordisk Focuses on Local Partnerships and Price Reductions Amidst Increasing Competition from Generic Weight-Loss Medications

05 Apr, 2026

Novo Nordisk Reduces Prices of Ozempic and Wegovy in India to Compete with Generic Brands | Whalesbook

05 Apr, 2026

Indian Court Grants Approval for Dr. Reddy's to Market Diabetes Medication Inventory

04 Apr, 2026

Prices of Ozempic and Wegovy decrease in India - ARY News

04 Apr, 2026

See More